Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2681 |
|
| Actual shortage: | 250 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2422 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
25 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-CLONIDINE | 0.1MG | TABLET | Resolved | 2021-08-13 | 2021-10-07 | 144108 |
| TEVA-CLONIDINE | 0.1MG | TABLET | Resolved | 2023-02-02 | 2023-04-28 | 183364 |
| ACT OLOPATADINE 0.2% | 0.2% | SOLUTION | Actual shortage | 2018-10-23 | 2018-10-23 | 65516 |
| TEVA-TRIACOMB | 0.25MG 2.5MG 100000UNIT 1MG | CREAM | Resolved | 2022-01-20 | 2023-07-14 | 153153 |
| TEVA-TRIACOMB | 0.25MG 2.5MG 100000UNIT 1MG | CREAM | Resolved | 2023-02-02 | 2023-07-14 | 183374 |
| TEVA-TRIACOMB | 0.25MG 2.5MG 100000UNIT 1MG | CREAM | Resolved | 2023-06-16 | 2023-07-06 | 195192 |
| TEVA-TRIACOMB | 0.25MG 2.5MG 100000UNIT 1MG | CREAM | Resolved | 2023-06-20 | 2023-07-06 | 195812 |
| TEVA-NABILONE | 0.25MG | CAPSULE | Resolved | 2017-08-01 | 2018-07-03 | 17899 |
| ACT PRAMIPEXOLE | 0.25MG | TABLET | Resolved | 2018-09-06 | 2019-04-11 | 60121 |
| TEVA-ROPINIROLE | 0.25MG | TABLET | Resolved | 2019-10-17 | 2020-04-02 | 96714 |
| TEVA-ROPINIROLE | 0.25MG | TABLET | Resolved | 2020-05-01 | 2020-08-17 | 113779 |
| TEVA-RISPERIDONE | 0.25MG | TABLET | Resolved | 2020-06-04 | 2020-07-09 | 116672 |
| TEVA-ROPINIROLE | 0.25MG | TABLET | Resolved | 2020-08-27 | 2020-11-12 | 123081 |
| ACT PRAMIPEXOLE | 0.25MG | TABLET | Resolved | 2020-09-24 | 2020-11-19 | 125001 |
| ACT PRAMIPEXOLE | 0.25MG | TABLET | Resolved | 2020-12-03 | 2020-12-17 | 129520 |
| ACT PRAMIPEXOLE | 0.25MG | TABLET | Resolved | 2021-01-28 | 2021-05-20 | 132652 |
| TEVA-RISPERIDONE | 0.25MG | TABLET | Resolved | 2021-05-20 | 2021-07-22 | 139749 |
| ACT PRAMIPEXOLE | 0.25MG | TABLET | Resolved | 2021-07-08 | 2021-09-02 | 142172 |
| ACT PRAMIPEXOLE | 0.25MG | TABLET | Avoided shortage | 2021-07-15 | 2021-07-15 | 142575 |
| TEVA-ROPINIROLE | 0.25MG | TABLET | Resolved | 2021-08-27 | 2023-06-09 | 144682 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63937 | ||
| DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63940 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-12 | 2018-10-12 | 63952 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 |